Bir Shyamal C, Ambekar Sudheer, Maiti Tanmoy Kumar, Nanda Anil
Department of Neurosurgery, Louisiana State University Health, 1501 Kings Highway, Shreveport, LA 71130-3932, USA.
Department of Neurosurgery, Louisiana State University Health, 1501 Kings Highway, Shreveport, LA 71130-3932, USA.
J Clin Neurosci. 2015 Jul;22(7):1117-22. doi: 10.1016/j.jocn.2014.12.017. Epub 2015 Mar 31.
We sought to evaluate the outcome of intracranial arteriovenous malformation (AVM) treated with gamma knife radiosurgery (GKRS) (Elekta, Stockholm, Sweden) as a primary treatment as well as an adjunct therapy. GKRS has emerged as an important treatment option for intracranial AVM. However, the long term outcome of GKRS on AVM is not well understood. We performed a retrospective review of 85 patients with AVM from 2000-2012 who received GKRS. Out of 85 patients, 13 had undergone prior embolization. The study population was monitored clinically and radiographically after GKRS treatment. Outcome following GKRS for intracranial AVM showed significant variations in nidus obliteration (obliteration in 67 [79%] patients and increase of nidus size on MRI in 18 [21%] patients). The median time to nidus obliteration was 31 months. Overall two (2.3%) patients had intracranial bleeding and the annual bleeding risk was 1.6% after GKRS. Predictive factors for obliteration of the nidus in patients with AVM were low AVM score, Spetzler-Martin grade I-III and female sex. Seventeen (20%) and one (1.17%) patients underwent repeat GKRS and resection, respectively, after initial GKRS, due to increased size of the nidus and GKRS related cyst formation. Thus, GKRS offers a high obliteration rate of AVM, low risk of intracranial bleeding and neurological morbidity, both as primary modality and as an adjunctive treatment. Therefore, GKRS is an effective treatment option for new patients with AVM as well as an adjuvant therapy in patients with recurrent AVM.
我们试图评估将伽玛刀放射外科治疗(GKRS)(瑞典斯德哥尔摩医科达公司)作为主要治疗方法以及辅助治疗手段时,颅内动静脉畸形(AVM)的治疗效果。GKRS已成为颅内AVM的一种重要治疗选择。然而,GKRS对AVM的长期治疗效果尚不完全清楚。我们对2000年至2012年间接受GKRS治疗的85例AVM患者进行了回顾性研究。85例患者中,13例曾接受过栓塞治疗。在GKRS治疗后,对研究人群进行了临床和影像学监测。颅内AVM接受GKRS治疗后的结果显示,病灶闭塞情况存在显著差异(67例[79%]患者病灶闭塞,18例[21%]患者MRI显示病灶大小增加)。病灶闭塞的中位时间为31个月。总体而言,有2例(2.3%)患者发生颅内出血,GKRS治疗后年出血风险为1.6%。AVM患者病灶闭塞的预测因素为低AVM评分、Spetzler-Martin I-III级以及女性。初始GKRS治疗后,分别有17例(20%)和1例(1.17%)患者因病灶增大和GKRS相关囊肿形成而接受了再次GKRS治疗和手术切除。因此,无论是作为主要治疗方式还是辅助治疗,GKRS都能实现较高的AVM闭塞率,且颅内出血和神经功能障碍风险较低。所以,GKRS对于新诊断的AVM患者是一种有效的治疗选择,对于复发性AVM患者也是一种辅助治疗方法。